Hematologic Medications and GI Medications Flashcards
Whole blood completion time
2-4 hours
Whole blood therapeutic use
Restore volume
Whole blood reaction monitoring (6)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Packed RBCs completion time
2-4 hours
Packed RBCs therapeutic uses (5)
- Increases available RBC
- Severe anemia
- Hemoglobinopathies
- Hemolytic anemias
- Erythroblastosis fetalis
Packed RBCs reaction monitoring (5)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Sepsis
Platelets completion time
15-30 minutes
Platelets therapeutic uses (5)
- Increased platelet count
- Active bleeding
- Thrombocytopenia
- Aplastic anemia
- Bone marrow suppression
Platelets reaction monitoring (2)
- Fever
- Sepsis
FFP completion time
30-60 minutes
FFP therapeutic uses
Replace clotting factors
FFP reaction monitoring (6)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Pheresed granulocytes completion time
45-60 minutes
Pheresed granulocytes therapeutic use (3)
- Severe neutropenia
- Neonatal sepsis
- Neutrophil dysfunction
Pheresed granulocytes reaction monitoring (6)
- Acute hemolytic
- Febrile
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Albumin 5% completion time
1-10ml/min
Albumin 25% completion time
4ml/min
Albumin therapeutic use (6)
- Expand volume by oncotic changes
- Hypovolemia
- Hypoalbuminemia
- Burns
- Severe nephrosis
- Hemolytic disease in newborns
Albumin reaction monitoring (2)
- Hypervolemia
- Pulmonary edema
Nursing interventions for blood product administration (6)
- Verify patient’s ID, name, blood type by 2 nurses
- Obtain baseline vitals
- IV access with 18-20 gauge catheter
- Prime tubing with 0.9% sodium chloride
- Stay with patient for first 15 minutes to monitor for signs of a reaction
- Complete infusion within 4 hours
Blood product reaction management (4)
- Stop infusion and take vitals
- Infuse 0.9% sodium chloride
- Notify provider
- Follow protocol for sending urine sample, CBC, bag/tubing to lab for analyzing
Hematopoietic growth factor action
Stimulate bone marrow to make specific blood cells
Hematopoietic growth factor medications (4)
- Epoietin alfa
- Filgrastim
- Pegfilgrastim
- Oprelvekin
Epoeitin alfa therapeutic use (2)
- Stimulate RBC production
- Anemia from chronic kidney disease, Retrovir therapy, chemo
Epoietin alfa side/adverse effects
- HTN
Epoietin alfa nursing interventions (3)
- Give subQ or IV
- Don’t agitate vial
- Monitor hematocrit/hemoglobin
Filgrastim/pegfilgrastim therapeutic uses (2)
- Stimulate WBC production
- Neutropenia due to cancer
Filgrastim/pegfilgrastim side/adverse effects (2)
- Bone pain
- Leukocytosis
Filgrastim/pegfilgrastim nursing interventions (3)
- SubQ/IV
- Don’t agitate vial
- Monitor CBC
Oprelvekin therapeutic uses (2)
- Stimulate platelet production
- Thrombocytopenia due to cancer
Oprelvekin side/adverse effects (3)
- Fluid retention
- Blurred vision
- Cardiac dysrhythmias
Oprelvekin nursing interventions (2)
- Give 6-24 hours after chemo
- SubQ
Oral iron nursing interventions (4)
- Dilute liquid with juice/water and give straw/syringe to avoid contact with the teeth
- Encourage orange juice fortified with vitamin C
- Avoid antacids, coffee, tea, dairy products, whole grain bread concurrently and 1 hour after giving due to decreased absorption
- Monitor for constipation and GI upset
IM iron nursing interventions (4)
- Use large bore needle 19-20 gauge 3 inch
- Change needle after drawing up from vial
- Z track method in ventrogluteal, never deltoid
- Don’t massage injection site
IV iron nursing interventions
- Administer small test dose and monitor patient for 15 minutes then slowly give additional dose
What to monitor while on heparin
aPTT every 4-6 hours
Parenteral anticoagulant nursing interventions (4)
- Monitor for signs of bleeding
- Safety precautions to prevent bleeding
- SubQ heparin in abdomen 2 inches from umbilicus and don’t aspirate/massage
- Rotate injection sites
Warfarin nursing interventions (5)
- Give once daily
- Monitor INR/PT can be self-monitored
- Avoid NSAIDS, medications with aspirin, alcohol
- Garlic, ginger, ginkgo can increase bleeding
- Ginseng can decrease effectiveness
Antiplatelet medications action
Prevent platelets from aggregating by blocking enzymes and factors that normally promote clotting
Antiplatelt medications (6)
- Aspirin
- Abciximab
- Clopidogrel
- Ticlopidine
- Pentoxifylline
- Dipyridamole
Antiplatelet precautions (2)
- Can’t be used in thrombocytopenia
- Use caution in patients with peptic ulcer disease
Antiplatelet side/adverse effects (3)
- Prolonged bleeding
- Gastric bleeding
- Thrombocytopenia
Thrombolytic medications action
Dissolve clots that have already formed by converting plasminogen to plasmin destroying fibrinogen and other clotting factors
Antacid action
Neutralize gastric acid and inactivate pepsin
Antacid medications (3)
- Aluminum hydroxide
- Magnesium hydroxide (milk of magnesia)
- Sodium bicarbonate
Aluminum hydroxide side/adverse effects (2)
- Constipation
- Hypophosphatemia
Magnesium hydroxide side/adverse effects (3)
- Diarrhea
- Renal impairment
- Hypermagnesemia
Sodium bicarbonate side/adverse effects
- Constipation
Therapeutic uses for antacids (2)
- Peptic ulcer disease
- GERD
Precautions for antacids (2)
- Prolonged use can result in hypophosphatemia
- Can decrease absorption of certain medications
Nursing interventions for antacids (4)
- Patients with renal impairments should only use aluminum-based precautions
- Take other medications 1 before/after antacids
- Older adults with poor nutritional status are at higher risk of hypophosphatemia
- Don’t self-prescribe antacid use longer than 2 weeks
Antisecretory/blocking agents action
Prevent/block selected receptors within the stomach
Antisecretory/blocking agents (2)
- PPIs
- H2 receptor antagonists
Antisecretory/blocking agents therapeutic uses (3)
- Gastric/duodenal ulcers
- GERD
- Zollinger-Ellison syndrome
Anti-secretory/blocking agents precautions (2)
- Can’t be used while lactating
- Use caution in patients with COPD
Anti-secretory/blocking agents side/adverse effects (3)
- Increase risk of osteoporosis with long term use, pneumonia in COPD, acid rebound (PPI)
- Decreased libido/impotence (H2 blocker)
- Lethargy, depression, confusion (H2 blocker)
Mucosal protectant medication
Sucralfate
Sucralfate action
Adhere to injured gastric ulcers upon contact with gastric acids, protective action for up to 6 hours, has no systemic effects
Sucralfate use (2)
- Gastric/duodenal ulcers
- GERD
Sucralfate precaution
- Chronic renal failure
Sucralfate interventions (2)
- Give on empty stomach at least 1 hour before meals
- Don’t give 30 minutes of antacids
Antiemetic medications (4)
- Promethazine
- Metoclopramide
- Ondansetron
- Scopolamine
Promethazine side/adverse effects (5)
- Drowsiness
- Anticholinergic effects
- Severe respiratory depression in kids younger than 2
- EPS
- Potentiate effects when given with narcotics
Promethazine precautions (2)
- Cardiovascular disease
- Hepatic disease
Promethazine nursing interventions (3)
- Monitor vitals
- Implement safety precautions
- For IM use large muscle
Metoclopramide side/adverse effects (5)
- Drowsiness
- Diarrhea
- Restlessness
- EPS
- Tardive dyskinesia
Metoclopramide precautions (3)
- Seizures
- Cardiovascular disease
- Pheochromocytoma
Metoclopramide nursing interventions (2)
- Teach patient about rapid GI emptying
- Stop if experiencing EPS
Ondansetron side/adverse effects (2)
- Headache
- EPS
Ondansetron nursing intervention
- Give tablets 30 minutes before chemo and 1 hour before radiation
Ondansetron precautions (2)
- Risk for dysrhythmias
- Not for patients with prolonged QT interval
Scopolamine side/adverse effects (3)
- Blurred vision
- Sedation
- Anticholinergic effects
Scopolamine precautions (2)
- Increased mydriatic effect causing increased ocular pressure
- Use caution in patients with glaucoma
Scopolamine nursing interventions (2)
- Apply patches behind the ear
- Use lubricating eye drops
Anti-diarrheal action
Activate opioid receptors in GI tract to decrease intestinal motility and increase absorption of fluid and sodium in the intestine
Anti-diarrheal medications (3)
- Diphenoxylate plus atropine
- Loperamide
- Paregoric
Anti-diarrheal precautions (2)
- Increased risk of mega colon for patients with IBS
- Paregoric can’t be used in patients with COPD
Anti-diarrheal side/adverse effects (4)
- Constipation
- Drowsiness
- Dry mouth
- Blurred vision
Anti-diarrheal nursing interventions (2)
- Monitor fluid/electrolytes
- Avoid caffeine as it increases motility
Stool softeners/laxatives medications (4)
- Psyllium
- Docusate sodium
- Bisacodyl
- Magnesium hydroxide
Psyllium use
Decrease diarrhea, bulk-forming
Docusate sodium use
Relieve constipation, surfactant
Bisacodyl use
Pre-procedure colon evacuation, stimulant
Magnesium hydroxide use (2)
- Prevent painful elimination, low-dose osmotic
- Promote rapid evacuation, high-dose osmotic
Stool softener/laxative precautions
- Can’t be used in patients with fecal impaction, bowel obstruction, ulcerative colitis, diverticulitis